Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lord

Showing results (111-120 of 223) with videos related to

Pageof 23
Sort By:
Communications Biology|November 9, 2021
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiencyIlirjana Bajrami, Callum Walker, Dragomir B Krastev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2010
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancerMonika Graeser, Afshan McCarthy, Christopher J Lord, et al.
Cancer Research|August 17, 2006
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibitionNuala McCabe, Nicholas C Turner, Christopher J Lord, et al.
Plos One|April 10, 2009
Integrated functional, gene expression and genomic analysis for the identification of cancer targetsElizabeth Iorns, Christopher J Lord, Anita Grigoriadis, et al.
Science Translational Medicine|October 15, 2010
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitorsKonstantin J Dedes, Daniel Wetterskog, Ana M Mendes-Pereira, et al.
The Journal of Pathology|February 19, 2015
Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumoursJeffrey C Francis, Lorenzo Melchor, James Campbell, et al.
Diabetes|May 27, 2003
Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD miceCarlos Penha-Gonçalves, Carolyn Moule, Luc J Smink, et al.
Nucleic Acids Research|May 11, 2012
Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationSimon S McDade, Alexandra E Henry, Geraldine P Pivato, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Pageof 23

Showing results (111-120 of 223) with videos related to

Sort By:
Pageof 23
Communications Biology|November 9, 2021
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiencyIlirjana Bajrami, Callum Walker, Dragomir B Krastev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2010
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancerMonika Graeser, Afshan McCarthy, Christopher J Lord, et al.
Cancer Research|August 17, 2006
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibitionNuala McCabe, Nicholas C Turner, Christopher J Lord, et al.
Plos One|April 10, 2009
Integrated functional, gene expression and genomic analysis for the identification of cancer targetsElizabeth Iorns, Christopher J Lord, Anita Grigoriadis, et al.
Science Translational Medicine|October 15, 2010
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitorsKonstantin J Dedes, Daniel Wetterskog, Ana M Mendes-Pereira, et al.
The Journal of Pathology|February 19, 2015
Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumoursJeffrey C Francis, Lorenzo Melchor, James Campbell, et al.
Diabetes|May 27, 2003
Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD miceCarlos Penha-Gonçalves, Carolyn Moule, Luc J Smink, et al.
Nucleic Acids Research|May 11, 2012
Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiationSimon S McDade, Alexandra E Henry, Geraldine P Pivato, et al.
Blood|May 11, 2012
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myelomaBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
The Journal of Cell Biology|September 19, 2019
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survivalCrystal A Tonnessen-Murray, Wesley D Frey, Sonia G Rao, et al.
Pageof 23